Healthcare and Pharmaceuticals industry

Irritable Bowel Syndrome Treatment market 2020 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The treatment of irritable bowel syndrome majorly revolves around relieving the patient from the symptoms associated with the condition, as the causes behind occurrence of irritable bowel syndrome are yet to be established. Patients suffering from irritable bowel syndrome show symptoms such as abdominal pain, diarrhea, and constipation. Long-term and recurring presence of these symptoms signals the possibility of irritable bowel syndrome. The treatment depends on severity of these symptoms, which are distinguished as mild, moderate, and severe. Mild symptoms do not significantly affect the quality of life. However, severe symptoms are more frequent and intense and need to be addressed. The disease is often linked with dietary, lifestyle factors, and stress, which can be controlled by managing stress levels, diet, and exercise. Severe symptoms need to be treated through medication prescribed by physicians. Two major therapy options are available for the treatment of IBS, namely, medical or drug therapy and nutritional therapy. Medical therapy includes drugs for relieving the symptoms and nutritional therapy by using fibers and probiotics or prebiotics depending on the situation.
Market Dynamics
The rise in number of gastrointestinal disorders are leading to increasing prevalence of irritable bowel syndrome, for which various companies such as Ironwood Pharmaceuticals, Inc. as well as NGOs conduct mass workshops for educating the people to incorporate healthy food habits as a major precaution towards prevention of IBS. Furthermore, major growth drivers for the irritable bowel syndrome treatment market are expected launches of various pipeline drugs for the treatment during the forecast period and increase in levels of stress associated with changing lifestyle as people suffering from IBS have a colon with sensitivity towards certain foods and stress. According to a survey by Buscopan IBS Relief in 2016, stress was the cause for seven out of ten patients suffering from gastrointestinal pain. The large population of stress and anxiety disorder patients are expected to fuel the growth of the global irritable bowel syndrome treatment market.
Market Taxonomy
This report segments the global irritable bowel syndrome treatment market on the basis of drug type, medical condition, and distribution channel. On the basis of drug type, the global irritable bowel syndrome treatment market is segmented into lubiprostone, linaclotide, eluxadoline, rifaximin, Ramosetron Hydrochloride and others. Medical conditions of irritable bowel syndrome includes IBS-constipation and IBS-diarrhea. Irritable bowel syndrome treatment market is segmented by distribution channel as hospital pharmacies, online pharmacies and retail pharmacies.
Key features of the study:
• This report provides in-depth analysis of irritable bowel syndrome treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017-2025), considering 2017 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global irritable bowel syndrome treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Abbott Laboratories*, Synergy Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Ardelyx, Inc., Astellas Pharma Inc., Novartis AG, GlaxoSmithKline plc., Ironwood Pharmaceuticals, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global irritable bowel syndrome treatment market report caters to various stakeholders in this industry including investors, suppliers, drug manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the Irritable Bowel Syndrome Treatment Market
Detailed Segmentation:
• Global Irritable Bowel Syndrome Treatment Market, By Drug Type:
o Lubiprostone
o Linaclotide
o Eluxadoline
o Rifaximin
o Ramosetron Hydrochloride
o Others
• Global Irritable Bowel Syndrome Treatment Market, By Medical Condition:
o IBS-Constipation
o IBS-Diarrhea
• Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel:
o Hospital Pharmacies
o Online Pharmacies
o Retail Pharmacies
• Global Irritable Bowel Syndrome Treatment Market, By Geography:
o North America
 By Drug Type:
 Lubiprostone
 Linaclotide
 Eluxadoline
 Rifaximin
 Ramosetron Hydrochloride
 Others
 By Medical Condition:
 IBS-Constipation
 IBS-Diarrhea
 By Distribution Channel:
 Hospital Pharmacies
 Online Pharmacies
 Retail Pharmacies
 By Country:
 U.S.
 Canada
o Europe
 By Drug Type:
 Lubiprostone
 Linaclotide
 Eluxadoline
 Rifaximin
 Ramosetron Hydrochloride
 Others
 By Medical Condition:
 IBS-Constipation
 IBS-Diarrhea
 By Distribution Channel:
 Hospital Pharmacies
 Online Pharmacies
 Retail Pharmacies
 By Country:
 U.K.
 Italy
 Spain
 Russia
 Rest of Europe
o Asia-Pacific
 By Drug Type:
 Lubiprostone
 Linaclotide
 Eluxadoline
 Rifaximin
 Ramosetron Hydrochloride
 Others
 By Medical Condition:
 IBS-Constipation
 IBS-Diarrhea
 By Distribution Channel:
 Hospital Pharmacies
 Online Pharmacies
 Retail Pharmacies
 By Country:
 China
 Japan
 ASEAN
 Rest of Asia Pacific
o Latin America
 By Drug Type:
 Lubiprostone
 Linaclotide
 Eluxadoline
 Rifaximin
 Ramosetron Hydrochloride
 Others
 By Medical Condition:
 IBS-Constipation
 IBS-Diarrhea
 By Distribution Channel:
 Hospital Pharmacies
 Online Pharmacies
 Retail Pharmacies
 By Country:
 Mexico
 Rest of Latin America
o Middle East
 By Drug Type:
 Lubiprostone
 Linaclotide
 Eluxadoline
 Rifaximin
 Ramosetron Hydrochloride
 Others
 By Medical Condition:
 IBS-Constipation
 IBS-Diarrhea
 By Distribution Channel:
 Hospital Pharmacies
 Online Pharmacies
 Retail Pharmacies
 By Country:
 Israel
 Rest of Middle East
o Africa
 By Drug Type:
 Lubiprostone
 Linaclotide
 Eluxadoline
 Rifaximin
 Ramosetron Hydrochloride
 Others
 By Medical Condition:
 IBS-Constipation
 IBS-Diarrhea
 By Distribution Channel:
 Hospital Pharmacies
 Online Pharmacies
 Retail Pharmacies
 By Country:
 South Africa
 Rest of Africa
• Company Profiles
o Abbott Laboratories *
 Company Overview
 Product Portfolio
 Financial Performance
 Key Strategies
 Recent Developments
 Future Plans
o Synergy Pharmaceuticals, Inc.
o Sucampo Pharmaceuticals, Inc.
o Valeant Pharmaceuticals International, Inc.
o Ardelyx, Inc.
o Astellas Pharma Inc.
o Novartis AG
o GlaxoSmithKline plc.
o Ironwood Pharmaceuticals, Inc.
"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet By Drug Type
? Market Snippet By Medical Condition
? Market Snippet By Distribution Channel
? Market Snippet By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Consumer Trends
o Impact Analysis
o FDA Approval Timeline
o PEST Analysis
o Probiotics & Prebiotics
4. Global Irritable Bowel Syndrome Treatment Market, By Drug Type, 2017 - 2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Lubiprostone
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Linaclotide
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Eluxadoline
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Rifaximin
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Ramosetron Hydrochloride
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
5. Global Irritable Bowel Syndrome Treatment Market, By Medical Condition, 2017 - 2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o IBS - Constipation
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o IBS - Diarrhea
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
6. Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel, 2017 - 2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Hospitals Pharmacies
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Retail Pharmacies
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Online Pharmacies
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
7. Global Irritable Bowel Syndrome Treatment Market, By Regions, 2017 - 2025 (US$ Mn)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2017 - 2025
o North America
? Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Medical Condition, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
? U.S.
? Canada
o Europe
? Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Medical Condition, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
? U.K.
? Italy
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Medical Condition, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
? China
? Japan
? ASEAN
? Rest of APAC
o Latin America
? Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Medical Condition, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
? Mexico
? Rest of Latin America
o Africa
? Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Medical Condition, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
? South Africa
? Rest of Africa
o Middle East
? Market Size and Forecast, By Drug Type, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Medical Condition, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Country , 2017 - 2025 (US$ Mn)
? Israel
? Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis (3x3 Matrix)
o Company Profiles
? Abbott Laboratories
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Synergy Pharmaceuticals, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Sucampo Pharmaceuticals, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Valeant Pharmaceuticals International, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Ardelyx, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Astellas Pharma Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Novartis AG
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? GlaxoSmithKline plc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Ironwood Pharmaceuticals, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 43 market data tables and 34 figures on "Irritable Bowel Syndrome Treatment Market - Global forecast to 2025".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.